![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/624949-134x100.jpg)
Ultrafiltration and diafiltration (UF/DF) processes that appear robust in development often reveal weaknesses during scale-up or tech transfer, creating capacity constraints, heavy manual intervention, timeline delays, and manufacturing risks. These failures frequently originate in early decisions that overlook scalability, system design, and cross-functional alignment. This on-demand webinar reviews four common pitfalls: incorrect filter sizing and membrane selection, dependence on manual operations, system design constraints, and breakdowns between PD and MSAT teams. Viewers gain strategies to build scalable UF/DF processes, reduce manual burden, and select systems that enable smoother tech transfer.